1 / 1

Bernard et al, Supplementary Figure S4

Bernard et al, Supplementary Figure S4. pTRE. pTRIP-DU3-TRE-MCS. Supplementary Figure S4. The pTRIP-DU3-TRE-MCS lentivector.

parley
Télécharger la présentation

Bernard et al, Supplementary Figure S4

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Bernard et al, Supplementary Figure S4 pTRE pTRIP-DU3-TRE-MCS Supplementary Figure S4. The pTRIP-DU3-TRE-MCS lentivector. The lentivector pTRIP-DU3-TRE-MCS was derived from the self-inactivating lentivectorpTRIP-DU3-EF1a-EGFP (1). The EF1a promoter was replaced by the tetracycline-inducible pTRE promoter from the vector pTRE-tight (Clontech) and a multiple cloning site (MCS) was inserted in place of the GFP gene. The cDNAs coding D133P53a, D133P53b, or D133P53g (XhoII-BamHI fragments), respectively, were subcloned into the SalI-BamHI sites of pTRIP-DU3-TRE-MCS. The resulting lentivector plasmids were pTRIP-TRE-D133P53a, -D133P53b, and -D133P53g . 1. Sirven A, Ravet E, Charneau P, et al. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol Ther 2001;3(4):438-48.

More Related